Quarry LP Has $182,000 Stake in Encompass Health Corporation $EHC

Key Points

• Quarry LP significantly reduced its stake in Encompass Health Corporation by 54.5%, leaving them with 1,793 shares valued at $182,000.
• Encompass Health reported a 12.0% year-over-year increase in quarterly revenue, totaling $1.46 billion, and exceeded earnings expectations with an EPS of $1.40.
• The company recently announced a quarterly dividend increase to $0.19 per share, representing an annualized yield of 0.6%.

Quarry LP cut its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 54.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,793 shares of the company's stock after selling 2,146 shares during the quarter. Quarry LP's holdings in Encompass Health were worth $182,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Invesco Ltd. increased its stake in Encompass Health by 5.1% in the first quarter. Invesco Ltd. now owns 5,818,783 shares of the company's stock valued at $589,326,000 after purchasing an additional 282,532 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in shares of Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock valued at $210,756,000 after buying an additional 424,691 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Encompass Health by 5.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company's stock valued at $189,549,000 after buying an additional 93,992 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Encompass Health by 13.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company's stock worth $184,571,000 after buying an additional 211,707 shares during the period. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in Encompass Health by 11.9% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company's stock worth $156,121,000 after acquiring an additional 163,400 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Stock Up 0.9%

EHC traded up $1.11 on Friday, hitting $125.59. 607,588 shares of the company were exchanged, compared to its average volume of 643,197. The stock's fifty day moving average is $116.93 and its 200-day moving average is $112.01. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $125.86. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market cap of $12.65 billion, a PE ratio of 24.58, a PEG ratio of 2.20 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the firm posted $1.11 EPS. The firm's revenue for the quarter was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.19 dividend. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.6%. Encompass Health's dividend payout ratio is presently 13.31%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on EHC shares. KeyCorp increased their price target on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Truist Financial boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. Wall Street Zen downgraded shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a report on Thursday, June 5th. Finally, UBS Group increased their price objective on shares of Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $134.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.